Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Biomimetic peptide and biodegradable delivery platform for the treatment of angiogenesis- and lymphangiogenesis-dependent diseases

Biomimetic peptide and biodegradable delivery platform for the treatment of angiogenesis- and lymphangiogenesis-dependent diseases

US Patent 10774112 · Granted Sep 15, 2020

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Bioreducible poly (beta-amino ester)s for siRNA delivery2025
Tolerogenic artificial antigen-presenting cells2024
Biodegradable biomimetic particles2024
Multicomponent degradable cationic polymers2024
Multicomponent degradable cationic polymers2024
Biomimetic peptide and biodegradable delivery platform for the treatment of angi2024
Biomimetic peptide and biodegradable delivery platform for the treatment of angi2024
Biomimetic peptide and biodegradable delivery platform for the treatment of angi2024
Biomimetic peptide and biodegradable delivery platform for the treatment of angi2024
Biomimetic peptide and biodegradable delivery platform for the treatment of angi2024
Nonviral gene transfer to the suprachoroidal space2024
Transcriptionally targeted and CpG-free plasmid for theranostic gene therapy2023